12:00 AM
Apr 13, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ALKS 33: Phase I data

Top-line data from a double-blind, placebo-controlled, U.S. Phase I trial in 16 healthy volunteers showed that ALKS 33 demonstrated rapid...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >